[1] Allemani C, Weir HK, Carreira H, et al.Global surveillance of cancer survival 1995-2009: Analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (concord-2)[J]. The Lancet, 2015, 385(9972):977-1010. [2] 陈万青, 李贺, 孙可欣, 等. 2014年中国恶性肿瘤发病和死亡分析[J]. 中华肿瘤杂志, 2018, 40(1):5-13. [3] Siegel RL, Miller KD, Jemal A.Cancer statistics, 2019[J]. CA Cancer J Clin, 2019, 69(1):7-34. [4] 郑荣寿, 孙可欣, 张思维, 等. 2015年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2019, 41(1):19028. [5] Ferlay J, Colombet M, Soerjomataram I, et al.Cancer incidence and mortality patterns in europe: Estimates for 40 countries and 25 major cancers in 2018[J]. Eur J Cancer, 2018, 103(8):358-387. [6] Islami F, Chen W, Yu XQ, et al.Cancer deaths and cases attributable to lifestyle factors and infections in China, 2013[J]. Ann Oncol, 2017, 28(10):2567-2574. [7] 陈万青, 郑荣寿, 张思维, 等. 2013年中国老年人群恶性肿瘤发病和死亡分析[J]. 中华肿瘤杂志, 2017, 39(2):60-67. [8] 陈万青, 左婷婷, 郑荣寿, 等. 2013年中国肺癌发病与死亡分析[J]. 中华肿瘤杂志, 2017, 39(10):795-800. [9] O'Rourke N, Roqué I Figuls M, et al. Concurrent chemoradiotherapy in non-small cell lung cancer[J]. Cochrane Database Syst Rev, 2010, 16(6):CD002140. [10] Kufe D, Weichselbaum R.Radiation therapy: activation of gene transcription and the development of genetic radiotherapy[J]. Cancer Biol Ther, 2003, 2:326-329. [11] Li X, Guo X, Cheng Y, et al.pH-responsive cross-linked low molecular weight polyethylenimine as an efficient gene vector for delivery of plasmid DNA encoding anti-VEGF-shRNA for tumor treatment[J]. Front Oncol, 2018, 8(1):354. [12] Lyons Y, Pradeep S, Wu S, et al.Macrophage depletion through colony stimulating factor 1 receptor pathway blockade overcomes adaptive resistance to anti-VEGF therapy[J]. Oncotarget, 2017, 8(57):96496-96505. [13] Ryoo NK, Lee J, Lee H, et al.Therapeutic effects of a novel siRNA-based anti-VEGF (siVEGF) nanoball for the treatment of choroidal neovascularization[J]. Nanoscale, 2017, 9(40):15461-15469. [14] Zhang L, Yang N, Mohamed-Hadley A, et al.Vector-based RNAi, a novel tool for isoform-specific knock-down of VEGF and anti-angiogenesis gene therapy of cancer[J]. Biochem Biophys Res Commun, 2003, 303(4):1169-1178. [15] Tudoran O, Berindan neagoe I, Balacescu O, et al. Evaluation of tumor angiogenesis through VEGF modulation in ovarian cancerin vivousing RNA interference[J]. Rom Biotech Lett,2009, 14(4):4560-4566. [16] Zhu H, Yun F, Shi X, et al.VEGF-C inhibition reverses resistance of bladder cancer cells to cisplatin via upregulating maspin[J]. Mol Med Rep, 2015, 12(2):3163-3169. [17] Matsumoto G, Kushibiki T, Kinoshita Y, et al.Cationized gelatin delivery of a plasmid DNA expressing small interference RNA for VEGF inhibits murine squamous cell carcinoma[J]. Cancer Sci, 2006, 97(4):313-321. [18] Ohta Y, Endo Y, Tanaka M, et al.Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer[J]. Clin Cancer Res, 1996, 2(8):1411-1416. [19] Senan S, Smit EF.Design of clinical trials of radiation combined with antiangiogenic therapy[J]. Oncologist, 2007, 12(4):465-477. [20] Zhu YM, Azahri NS, Yu DC, et al.Effects of COX-2 inhibition on expression of vascular endothelial growth factor and interleukin-8 in lung cancer cells[J]. BMC Cancer, 2008, 8:218. [21] Rich JN.Cancer stem cells in radiation resistance[J]. Cancer Res, 2007, 67(19):8980-89804. [22] Nur SM, Hasan MA, Amin MA, et al.Design of potential RNAi (miRNA and siRNA) molecules for middle east respiratory syndrome coronavirus (MERS-CoV) gene silencing by computational method[J]. Interdiscip Sci, 2015, 7(3):257-265. [23] Fire A, Xu S, Montgomery MK, et al.Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans[J]. Nature, 1998, 391(6669):806-811. [24] Jie Z, Mo C, Cai-cun Z, et al. Influences of over-expression of VEGF-C and its inhibition on biological characteristics of NCI-H446 human small-cell lung cancer cells[J]. Tumor, 2012, 32(2):11-18. [25] Barr MP, Gray SG, Gately K, et al.Vascular endothelial growth factor is an autocrine growth factor, signaling through neuropilin-1 in non-small cell lung cancer[J]. Mol Cancer, 2015, 14:45. [26] Zhou HB, Yin YF, Hu Y, et al.Suppression of vascular endothelial growth factor via siRNA interference modulates the biological behavior of human nasopharyngeal carcinoma cells[J]. Jpn J Radiol, 2011, 29(9):615-622. [27] Lecaros RL, Huang L, Lee TC, et al.Nanoparticle delivered VEGF-A siRNA enhances photodynamic therapy for head and neck cancer treatment[J]. Mol Ther, 2015, 169:65-74. |